Catalyst Pharmaceuticals Announces Issuance of Mandate by the U.S. Court of Appeals for the 11th Circuit Directing the District Court Judge in Catalyst’s Lawsuit Against the FDA to Grant Summary Judgement in Favor of Catalyst
CORAL GABLES, Fla., Jan. 28, 2022 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX),…